Prostate Cancer News and Research

Latest Prostate Cancer News and Research

Scientists develop new resources to combat cancer, advance cutting-edge genomics research

University of Virginia School of Medicine scientists have developed important new resources that will aid the battle against cancer and advance cutting-edge genomics research.

27 May 2021

Scientists propose new strategies to find drugs that neutralize critical enzymes

Scientists from the University of Bath explore racemases and propose strategies for finding drugs that target these important enzymes.

26 May 2021

New study may lead to better treatments for prostate, ovarian, and breast cancers

Researchers at UVA Cancer Center have unveiled important new insights into how hormones known as androgens act on our cells – and the discovery could boost efforts to develop better treatments for prostate, ovarian and breast cancers.

21 May 2021

Combination approach can improve the success rate of cancer treatment

A new cancer vaccine could boost the positive effects of existing immunotherapy drugs, improving the success rate of treatments from 20% to 75% of cases, according to a new study by immunologists from the University of Konstanz.

19 May 2021

Cancer patients without health insurance had significantly worse survival than Medicare beneficiaries

MUSC Hollings Cancer Center lung cancer researcher Gerard Silvestri, M.D., found that a lack of insurance leads to worse cancer survival than for those with Medicare, in a paper published in the May issue of Health Affairs.

17 May 2021

Study suggests new avenues for treating Black patients who disproportionately die of prostate cancer

A study designed to enroll an equal number of Black and white men with advanced prostate cancer confirms key findings that have been evident in retrospective analyses and suggest potential new avenues for treating Black patients who disproportionately die of the disease.

7 May 2021

Key mechanism behind mutant p53 aggregation process is linked to cancer pathology

Cancer has been recently shown to be affected by protein clusters, particularly by the aggregation of mutant variants of the tumor suppressor protein p53, which are present in more than half of malignant tumors.

5 May 2021

Could in vitro glycoengineering help produce better SARS-CoV-2 spike candidates for vaccine research?

A vexing problem in the development of vaccines has been the need to achieve the right glycosylation profile for the viral antigens. A new study, recently released as a preprint on the bioRxiv* server, shows how a sequential cell-free approach produced complex N-glycans from simpler types, in a one-pot reaction.

4 May 2021

Arresting tumor growth for a variety of cancers through T cell engineering

Through T cell engineering, researchers at Virginia Commonwealth University Massey Cancer Center show that it's possible to arrest tumor growth for a variety of cancers and squash the spread of cancer to other tissues.

30 Apr 2021

Thousands of men to trial new home test kit for prostate cancer

Thousands of men worldwide are to receive a home test kit for prostate cancer – thanks to pioneering research from the University of East Anglia and the Norfolk and Norwich University Hospital (NNUH).

30 Apr 2021

Medicare could save nearly $500 million per year by reducing use of low-value preventive care services

A UCLA-led study shows that physicians frequently order preventive medical services for adult Medicare beneficiaries that are considered unnecessary and of "low value" by the U.S. Preventive Services Task Force - at a cost of $478 million per year.

29 Apr 2021

Study shows decline in prostate cancer diagnoses during the pandemic

During the first wave of the corona pandemic, 36 per cent fewer men were diagnosed with prostate cancer in Sweden than in previous years.

29 Apr 2021

City of Hope initiates Phase 2 clinical trial to investigate if mushroom tablets could slow prostate cancer

City of Hope, a world-renowned independent research and treatment center for cancer, diabetes and other life-threatening diseases, is now recruiting patients for a Phase 2 clinical trial to investigate whether pills containing white button mushroom extract could regulate the immune system, affecting prostate-specific antigen (PSA) levels to either remain stable or decline.

29 Apr 2021

Male bladder cancer vulnerability could be exploited to design new therapeutic strategies

A protein variant common in malignant bladder tumor cells may serve as a new avenue for treating bladder cancer.

29 Apr 2021

New method could be used to develop more effective treatments for cancer, metabolic disorders

Researchers from the University of Copenhagen have developed a new method that makes it possible to control human hormones and metabolism.

28 Apr 2021

CU Cancer Center researchers receive PRCRP grant to investigate metastasis

Two members of the University of Colorado Cancer Center have received prestigious Idea Awards from the U.S. Department of Defense's Peer Reviewed Cancer Research Program.

27 Apr 2021

New urine test for prostate cancer shows aggressiveness of the disease

Researchers from the University of East Anglia have developed a new urine test for prostate cancer which also shows how aggressive the disease is.

27 Apr 2021

Hormonal therapies for breast and prostate cancers increase the risk of heart attack, stroke

The hormonal therapies used to treat many breast and prostate cancers raise the risk of a heart attack and stroke, and patients should be monitored regularly and receive treatment to reduce risk and detect problems as they occur.

26 Apr 2021

FDA approves clinical trials to test the safety of cancer-detection technology

The U.S. Food and Drug Administration has approved human clinical trials to test the safety of cancer-detection technology developed at Case Western Reserve University: a tumor-targeting contrast agent that accurately detects aggressive prostate cancer in a magnetic resonance imaging (MRI) scan.

22 Apr 2021

Henry Ford receives $250,000 grant to reduce prostate cancer disparities among Black men

Henry Ford Cancer Institute has received a $250,000 grant from Pfizer Global Medical Grants and the American Cancer Society to reduce prostate cancer disparities among Black men.

21 Apr 2021

Prostate Cancer News and Research

Latest Prostate Cancer News and Research

Scientists develop new resources to combat cancer, advance cutting-edge genomics research

Scientists propose new strategies to find drugs that neutralize critical enzymes

New study may lead to better treatments for prostate, ovarian, and breast cancers

Combination approach can improve the success rate of cancer treatment

Cancer patients without health insurance had significantly worse survival than Medicare beneficiaries

Study suggests new avenues for treating Black patients who disproportionately die of prostate cancer

Key mechanism behind mutant p53 aggregation process is linked to cancer pathology

Could in vitro glycoengineering help produce better SARS-CoV-2 spike candidates for vaccine research?

Arresting tumor growth for a variety of cancers through T cell engineering

Thousands of men to trial new home test kit for prostate cancer

Medicare could save nearly $500 million per year by reducing use of low-value preventive care services

Study shows decline in prostate cancer diagnoses during the pandemic

City of Hope initiates Phase 2 clinical trial to investigate if mushroom tablets could slow prostate cancer

Male bladder cancer vulnerability could be exploited to design new therapeutic strategies

New method could be used to develop more effective treatments for cancer, metabolic disorders

CU Cancer Center researchers receive PRCRP grant to investigate metastasis

New urine test for prostate cancer shows aggressiveness of the disease

Hormonal therapies for breast and prostate cancers increase the risk of heart attack, stroke

FDA approves clinical trials to test the safety of cancer-detection technology

Henry Ford receives $250,000 grant to reduce prostate cancer disparities among Black men

What to know about prostate cancer eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Prostate Cancer News and Research

Latest Prostate Cancer News and Research

What to know about prostate cancer eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in